MedImmune
Leading Global Biologics R&D | MedImmune.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD24.1b (Public information from Apr 2007)
Company register number 03854275
Gaithersburg Maryland (HQ)
Corporate Venture Fund: MedImmune Ventures
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$15.6b Valuation: $15.6b | Acquisition | ||
| Total Funding | - | ||
Related Content
Recent News about MedImmune
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
Investments by MedImmune
Edit
ACQUISITION by MedImmune Nov 2014
exited
ACQUISITION by MedImmune Sep 2014
ACQUISITION by MedImmune Aug 2013
ACQUISITION by Novo Nordisk Jun 2020
